Detecting meiotic disruption involves cytogenetic studies and the use of biomarkers. Fluorescence in situ hybridization (FISH) and karyotyping are common techniques used to identify chromosomal abnormalities. Biomarkers, such as proteins associated with DNA repair, can indicate meiotic disturbances due to toxic exposure.
